We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Antimicrobial Resistance of Bacteria in Burn Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00794742
Recruitment Status : Completed
First Posted : November 20, 2008
Last Update Posted : April 13, 2015
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this study is to test the resistance of pathogenic bacteria in infected tissues of burn patients to various antimicrobials and enzyme debriders.

Condition or disease

Detailed Description:
Bacteria that is present in infected burn wounds will be isolated and identified. The isolates will be tested for resistance to commercially available antimicrobials.

Study Design

Study Type : Observational
Actual Enrollment : 32 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Analyzing the Antimicrobial Resistance Profile of Bacterial Isolates Obtained From Severely Burned Patients
Study Start Date : November 2008
Primary Completion Date : May 2014
Study Completion Date : May 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Antibiotics Burns
U.S. FDA Resources

Groups and Cohorts

Burn Wounds
Patients with burn wounds

Outcome Measures

Primary Outcome Measures :
  1. Types of bacteria [ Time Frame: 28 days ]

Biospecimen Retention:   Samples Without DNA
Bacterial isolates of infected burn wounds

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with open,unhealed,burn wounds

Inclusion Criteria:

  • Males and females of any age
  • Have open, unhealed wounds(s) that will be cultured per standard of care
  • Subject or authorized representative provide informed consent

Exclusion Criteria:

  • Informed consent not provided or able to be obtained
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00794742

United States, Texas
University Medical Center
Lubbock, Texas, United States, 79415
Sponsors and Collaborators
Texas Tech University Health Sciences Center
Principal Investigator: John Griswold, M.D. Texas Tech University Health Sciences Center
More Information

Responsible Party: Texas Tech University Health Sciences Center
ClinicalTrials.gov Identifier: NCT00794742     History of Changes
Other Study ID Numbers: TTUHSC-L09-014
First Posted: November 20, 2008    Key Record Dates
Last Update Posted: April 13, 2015
Last Verified: April 2015

Keywords provided by Texas Tech University Health Sciences Center:

Additional relevant MeSH terms:
Anti-Infective Agents
Anti-Bacterial Agents